https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-04-01 / Lancet 2000 Apr;355(9210):1119-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-04-01 / Lancet 2000 Apr;355(9210):1119-252000-04-01 00:00:002019-02-15 08:35:52Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-03-17 / Dtsch. Med. Wochenschr. 2000 Mar;125(11):317-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-03-17 / Dtsch. Med. Wochenschr. 2000 Mar;125(11):317-92000-03-17 00:00:002000-03-17 00:00:00[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-852000-01-01 00:00:002000-01-01 00:00:00Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-11-01 / Int J Hyperthermia 1999 Nov-Dec;15(6):475-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-11-01 / Int J Hyperthermia 1999 Nov-Dec;15(6):475-861999-11-01 00:00:001999-11-01 00:00:00Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-07-01 / Anticancer Res. 1999 Jul-Aug;19(4C):3403-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-07-01 / Anticancer Res. 1999 Jul-Aug;19(4C):3403-81999-07-01 00:00:002019-02-15 08:39:25Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-04-01 / J. Immunol. 1999 Apr;162(7):3757-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-04-01 / J. Immunol. 1999 Apr;162(7):3757-601999-04-01 00:00:002019-02-15 09:18:04Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-03-01 / Int J Hyperthermia 1999 Mar-Apr;15(2):79-107
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-03-01 / Int J Hyperthermia 1999 Mar-Apr;15(2):79-1071999-03-01 00:00:002019-02-15 09:17:58For the clinical application of thermochemotherapy given at mild temperatures
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-81999-01-09 00:00:002019-02-15 09:18:00[Hyperthermia in combination with chemotherapy in gynecological cancers]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Cancer Chemother. Pharmacol. 1999;43(5):409-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Cancer Chemother. Pharmacol. 1999;43(5):409-141999-01-01 00:00:002019-02-15 09:17:59A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-71999-01-01 00:00:001999-01-01 00:00:00Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice
